Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
Q4 2022 vs. Q3 2022
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 21 | 25 | +4 |
| Shares | 3.72M | 3.93M | +215.4K (+5.8%) |
| Value | $36.1M | $39.6M | +$3.49M (+9.7%) |
New holders (8)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 500,000 | $5.08M | 0.06% |
| Bank of Montreal | 316,628 | $3.22M | 0.00% |
| Elequin Capital LP | 169,700 | $1.73M | 0.49% |
| Cubist Systematic Strategies, LLC | 95,510 | $971.3K | 0.01% |
| PenderFund Capital Management Ltd. | 53,100 | $731.0K | 0.22% |
| Karpus Management, Inc. | 24,200 | $246.1K | 0.01% |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 13,400 | $136.0K | 0.00% |
| UBS Group AG | 24 | $244 | 0.00% |
Sold out (4)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Logan Stone Capital, LLC | 149,600 | $1.47M |
| Cowen and Company, LLC | 90,624 | $893.0K |
| Wolverine Asset Management LLC | 17,943 | $176.0K |
| Old Mission Capital LLC | 12,704 | $125.0K |